ストックスクリーナーアプリを入手
478.82
0.99%
-4.80
プレマーケット:
479.02
0.20
+0.04%
前日終値:
$483.62
開ける：
$484.498
24時間の取引高:
2.89M
Relative Volume:
1.45
時価総額：
$170.06B
収益：
$10.58B
当期純損益:
$3.00B
株価収益率:
58.08
EPS:
8.2437
ネットキャッシュフロー:
$2.83B
1週間 パフォーマンス:
+4.53%
1か月 パフォーマンス:
+0.16%
6か月 パフォーマンス:
-13.15%
1年 パフォーマンス:
-1.87%
1日の値動き範囲:
$477.19
$489.86
1週間の範囲:
$451.29
$491.15
52週間の値動き範囲:
$427.84
$603.88
Intuitive Surgical Inc Stock (ISRG) Company Profile
Compare ISRG vs BDX, MDLN, ALC, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
478.82 | 160.28B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
154.85 | 44.57B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
46.23 | 38.56B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
75.86 | 37.93B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
219.51 | 32.23B | 5.40B | 1.49B | 1.78B | 10.12 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-11 | アップグレード | Citigroup | Neutral → Buy |
| 2026-01-27 | 開始されました | TD Cowen | Buy |
| 2025-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-07-23 | ダウングレード | Erste Group | Buy → Hold |
| 2025-06-09 | ダウングレード | Deutsche Bank | Hold → Sell |
| 2025-06-05 | アップグレード | Erste Group | Hold → Buy |
| 2024-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | アップグレード | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | 繰り返されました | Citigroup | Buy |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2023-11-17 | 開始されました | HSBC Securities | Buy |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-04-19 | 繰り返されました | BTIG Research | Buy |
| 2023-04-19 | 繰り返されました | BofA Securities | Buy |
| 2023-04-19 | 繰り返されました | Citigroup | Buy |
| 2023-04-19 | 繰り返されました | Evercore ISI | In-line |
| 2023-04-19 | 繰り返されました | JP Morgan | Overweight |
| 2023-04-19 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2023-04-19 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2023-04-19 | 繰り返されました | Raymond James | Outperform |
| 2023-04-19 | 繰り返されました | Stifel | Buy |
| 2023-04-19 | 繰り返されました | Truist | Buy |
| 2023-04-19 | 繰り返されました | Wells Fargo | Overweight |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-03-23 | 開始されました | William Blair | Outperform |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-13 | 開始されました | Mizuho | Neutral |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-04-13 | 開始されました | Truist | Buy |
| 2022-04-06 | 開始されました | Wolfe Research | Peer Perform |
| 2022-03-25 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-02 | アップグレード | UBS | Neutral → Buy |
| 2022-01-31 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | ダウングレード | Redburn | Buy → Neutral |
| 2022-01-21 | 繰り返されました | BTIG Research | Buy |
| 2022-01-21 | アップグレード | Citigroup | Neutral → Buy |
| 2022-01-21 | 繰り返されました | Deutsche Bank | Hold |
| 2022-01-21 | 繰り返されました | Evercore ISI | In-line |
| 2022-01-21 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2022-01-21 | 繰り返されました | Piper Sandler | Neutral |
| 2022-01-21 | 繰り返されました | Raymond James | Outperform |
| 2022-01-21 | 繰り返されました | Robert W. Baird | Outperform |
| 2022-01-21 | 繰り返されました | Stifel | Buy |
| 2022-01-21 | 繰り返されました | UBS | Neutral |
| 2022-01-21 | 繰り返されました | Wells Fargo | Overweight |
| 2022-01-10 | アップグレード | BTIG Research | Neutral → Buy |
| 2021-10-01 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-07-21 | 繰り返されました | BofA Securities | Neutral |
| 2021-07-21 | 繰り返されました | Citigroup | Buy |
| 2021-07-21 | 繰り返されました | JP Morgan | Overweight |
| 2021-07-21 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2021-07-21 | 繰り返されました | Piper Sandler | Neutral |
| 2021-07-21 | 繰り返されました | SVB Leerink | Mkt Perform |
| 2021-07-21 | 繰り返されました | Stifel | Buy |
| 2021-07-21 | 繰り返されました | UBS | Neutral |
| 2021-07-21 | 繰り返されました | Wells Fargo | Overweight |
| 2021-07-14 | 繰り返されました | Goldman | Buy |
| 2021-06-01 | アップグレード | Evercore ISI | Underperform → In-line |
| 2021-04-21 | アップグレード | Oppenheimer | Underperform → Perform |
| 2021-04-21 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | 開始されました | Citigroup | Buy |
| 2020-12-15 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | 開始されました | Argus | Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Outperform |
| 2020-09-08 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-09-02 | 開始されました | Robert W. Baird | Neutral |
| 2020-07-20 | 繰り返されました | Bernstein | Outperform |
| 2020-04-28 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | ダウングレード | CFRA | Hold → Sell |
| 2020-04-17 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | ダウングレード | Evercore ISI | In-line → Underperform |
| 2020-04-01 | ダウングレード | Oppenheimer | Perform → Underperform |
| 2020-01-27 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2019-12-12 | 繰り返されました | Wells Fargo | Outperform |
| 2019-11-21 | 開始されました | Oppenheimer | Perform |
| 2019-07-19 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-04-22 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-04-02 | 開始されました | Deutsche Bank | Buy |
| 2018-10-31 | 繰り返されました | Piper Jaffray | Overweight |
| 2018-10-19 | アップグレード | Canaccord Genuity | Hold → Buy |
すべてを表示
Intuitive Surgical Inc (ISRG) 最新ニュース
Intuitive Surgical, Inc. (ISRG) is attracting investor attention: Here is what you should know - MSN
Is Intuitive Surgical a buy right now? - MSN
ISRG Maintains Overweight Rating by Barclays -- Price Target Low - GuruFocus
Does Intuitive Surgical Have More Room to Run After Q1 Beat? - Barchart
Intuitive Surgical’s Selloff Sets Up a 30% Rebound Opportunity - Investing.com
Intuitive Surgical's Selloff Sets Up a 30% Rebound Opportunity - MarketBeat
The Biggest Takeaway From ISRG Earnings - Forbes
Is Innovation-Led Growth Driving ISRG's Revenues Above Procedures? - Yahoo Finance
Wells Fargo Reaffirms Their Buy Rating on Intuitive Surgical (ISRG) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Rapport Therapeutics, Inc. (RAPP), Danaher (DHR) and Intuitive Surgical (ISRG) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG), Quest Diagnostics (DGX) and Merck & Company (MRK) - The Globe and Mail
Intuitive Surgical: Forget The 40x P/E. Focus On The 10-Year Potential (Upgrade) - Seeking Alpha
Intuitive Surgical Is A Buy Despite Soaring Post-Earnings (NASDAQ:ISRG) - Seeking Alpha
Why Intuitive Surgical (ISRG) Stock Is Up Today - Yahoo Finance UK
Intuitive Surgical’s Money Printer Keeps Humming: 13 Quarters of Double-Digit Growth and Counting - NAI500
Intuitive Surgical Stock Analysis: Buy or Sell? - The Motley Fool
Could This Healthcare Stock Help You Build a Real Fortune Over the Next 20 Years? - The Motley Fool
Intuitive Surgical Earnings Call Signals Robust Growth - TipRanks
Buy UnitedHealth or Intuitive Surgical Stock After Strong Q1 Results? - Zacks Investment Research
Intuitive Surgical Q1 Highlights Recurring Strength And AI Driven Platform Usage - simplywall.st
Intuitive Surgical reports $2.77B revenue, $2.28 diluted EPS in 10-Q - TradingView
Intuitive Surgical Balances Growth In AI Surgery With Cybersecurity Lessons - Yahoo Finance
Intuitive Surgical (NASDAQ: ISRG) posts strong Q1 2026 growth and big buyback - Stock Titan
Intuitive Surgical (ISRG) Shares Surge Over 7% After Strong Q1 R - GuruFocus
Why Robotic Surgery's Titan, Intuitive Surgical, Just Made A Bullish Move - Investor's Business Daily
Intuitive Surgical Reports Another Blowout Quarter: Time to Buy the Stock? - The Motley Fool
Why Intuitive Surgical Stock Soared Today - The Motley Fool
Intuitive Surgical raises 2026 outlook as robotic surgery grows - Modern Healthcare
Intuitive Surgical: Strong Quarter, Mispriced Stock (NASDAQ:ISRG) - Seeking Alpha
Intuitive Surgical Jumps 7% on Earnings Beat and Raised Full-Year Outlook - TradingView
Intuitive Surgical Q1 results top estimates as robotic surgery demand accelerates - Proactive financial news
Intuitive Surgical lifts 2026 outlook for da Vinci robot procedure growth - MedTech Dive
Intuitive Surgical raises guidance on strong commercial momentum - marketscreener.com
Intuitive Surgical Price Target Maintained With a $574.00/Share by BTIG - Moomoo
ISRG Stock Up as Q1 Earnings & Sales Beat Estimates on Procedure Growth - TradingView
How ISRG Just Secured The U.S. Market - Trefis
ISRG Maintained by Baird -- Price Target Raised to $610 - GuruFocus
Intuitive Surgical (ISRG) Surges 7% on Strong Q1 Earnings and Up - GuruFocus
ISRG Maintains Rating by Leerink Partners -- Price Target Lowered to $573 - GuruFocus
Goldman Sachs Adjusts Intuitive Surgical Price Target to $621 From $609, Maintains Buy Rating - Moomoo
Intuitive Surgical rises as analysts cheer Q1 beat, guidance raise - MSN
Intuitive Surgical's Q1 Beat Shows Robotic Surgery Growth Is Holding Up - Benzinga
Piper Sandler lowers Intuitive Surgical stock price target to $580 - Investing.com
Intuitive Surgical stock rises after Q1 beat (ISRG:NASDAQ) - Seeking Alpha
Why Intuitive Surgical Stock Is Powering Higher - TipRanks
Barclays lowers Intuitive Surgical stock price target to $651 By Investing.com - Investing.com Australia
Intuitive Surgical Inc Stock (ISRG) Moved Up by 7.01% on Apr 22: What Investors Need To Know - TradingKey
HSBC Adjusts Price Target on Intuitive Surgical to $604 From $653, Maintains Buy Rating - marketscreener.com
ISRG Maintained by Piper Sandler -- Price Target Lowered to $580 - GuruFocus
Intuitive Surgical Analysts Boost Their Forecasts After Upbeat Q1 Earnings - Benzinga
Barclays lowers Intuitive Surgical stock price target to $651 - Investing.com
Intuitive Surgical Inc (ISRG) 財務データ
収益
当期純利益
現金流量
EPS
0.51%
12.86%
大文字化:
|
ボリューム (24 時間):